Skip to content

Clinical comparative efficacy of Polyherbal Unani formulations in the treatment of QULA ‘(Aphthous stomatitis)

A clinical study to evaluate the efficacy of Polyherbal Unani formulations in the management of QULA ‘(Aphthous stomatitis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072022
Enrollment
60
Registered
2024-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K120- Recurrent oral aphthae

Interventions

Intervention1: Oral Jawarish-i-Mastagi and Gargle with decoction of Barg-i-Hina: Patients in this group will be provided Jawarish-i-Mastagi orally in a dosage of 6 gm twice daily for 14 days and gargl

Sponsors

State Unani Medical College and HAHRDM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The following participants will be included in the study: 1. Participants of any sex in the age group of 18-65 years 2. Presence of single/multiple ulcer in the oral cavity or tongue 3. Presence of any of the following symptoms: Difficulty in eating/chewing/speaking/swallowing, burning sensation, pain in oral cavity, coated tongue, excessive salivation. 4. Participants who are willing to sign consent form and ready for follow- up

Exclusion criteria

Exclusion criteria: The following participants will be excluded: 1. Pregnant and lactating mothers. 2. Those have history of systematic underlying disease (Crohn’s disease, Ulcerative Colitis, Behcet’s syndrome, Sweet’s Syndrome, Lupus erythematosus) and metabolic disease (Diabetes mellitus, hypertension and AIDS). 3. Those diagnosed with any other disease of Oral cavity such as Carcinoma 4. Participants of renal, hepatic and severe cardiac disease 5. Participants unsure about attending treatment schedule regularly 6. Those are not signing on consent form.

Design outcomes

Primary

MeasureTime frame
The response to treatment will be assessed using the following parameters: 1. LIKERT Scale 2. Visual Analogue Scale (VAS)Timepoint: Day 7 and 14.

Secondary

MeasureTime frame
Clinical assessment will be done & the response to treatment will be assessed using the following parameters: 1. LIKERT Scale Timepoint: week 1 & week 2.

Countries

India

Contacts

Public ContactDr Mohd Asif Hussain Usmani

State Unani Medical College

drnadeemahmad85@gmail.com9369081365

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026